Trial · NCT04800393
The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.
NCT04800393, Not applicable, Recruiting, Moscow Clinical Scientific Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial. Trials, record NCT04800393. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04800393
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.
- NCT number
- NCT04800393
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 130 participants, estimated
- Lead sponsor
- Moscow Clinical Scientific Center
- Conditions
- Anesthesia, Breast Cancer
- Interventions
- Sevoflurane, Propofol
- First posted
- 2021-03-16
- Last updated
- 2023-04-26
Source ClinicalTrials.gov
Registered outcomes40
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Neutrophil-lymphocyte ratio | 1 hour after surgery | Absolute number of neutrophils divided by the absolute number of lymphocytes |
| Primary | Neutrophil-lymphocyte ratio | 24 hours after surgery | Absolute number of neutrophils divided by the absolute number of lymphocytes |
| Secondary | Matrix metallopeptidase 9 | 1 hour after surgery | ng/mL |
| Secondary | Matrix metallopeptidase 9 | 24 hour after surgery | ng/mL |
| Secondary | C-reactive protein | 1 hour after surgery | mg/L |
| Secondary | C-reactive protein | 24 hour after surgery | mg/L |
| Secondary | Natural killer cells of blood (CD3-CD16 +) | 1 hour after surgery | Absolute number (х 10\^9 /L) |
| Secondary | Natural killer cells of blood (CD3-CD16 +) | 24 hour after surgery | Absolute number (х 10\^9 /L) |
| Secondary | Immunoregulatory index of T helpers (CD3 + CD4 +) / cytotoxic T cells (CD3 + CD8 +) | 1 hour after surgery | the ratio of T helper cells to cytotoxic T cells |
| Secondary | Immunoregulatory index of T helpers (CD3 + CD4 +) / cytotoxic T cells (CD3 + CD8 +) | 24 hour after surgery | the ratio of T helper cells to cytotoxic T cells |
1 to 10 of 40Source ClinicalTrials.gov
See all 40 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04800393
GET https://conductscience.org/api/trials/v1/NCT04800393/registered?page=2